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Abstract
Background: The burden of methicillin resistant Staphylococcus aureus is a major public health concern worldwide;
however the overall epidemiology of multidrug resistant strains is neither coordinated nor harmonized, particularly
in developing countries including Ethiopia. Therefore, the aim of this meta-analysis was to assess the burden of
methicillin resistant Staphylococcos aureus and its antibiotic resistance pattern in Ethiopia at large.
Methods: PubMed, Google Scholar, and lancet databases were searched and a total of 20 studies have been
selected for meta-analysis. Six authors have independently extracts data on the prevalence of methicillin resistant
Staphylococcus aureus among clinical isolates of Staphylococcus aureus. Statistical analysis was achieved by using
Open meta-analyst (version 3.13) and Comprehensive meta-analysis (version 3.3) softwares. The overall prevalence
of methicillin resistant Staphylococcus aureus and its antibiotic resistance pattern were pooled by using the forest
plot, table and figure with 95% CI.
Results: The pooled prevalence of methicillin resistant Staphylococcus aureus was 32.5% (95% CI, 24.1 to 40.9%).
Moreover, methicillin resistant Staphylococcus aureus strains were found to be highly resistant to penicillin,
ampicillin, erythromycin, and amoxicillin, with a pooled resistance ratio of 99.1, 98.1, 97.2 and 97.1%, respectively.
On the other hand, comparably low levels of resistance ratio were noted to vancomycin, 5.3%.
Conclusion: The overall burden of methicillin resistant Staphylococcus aureus is considerably high, besides these
strains showed extreme resistance to penicillin, ampicillin, erythromycin and amoxicillin. In principle, appropriate use
of antibiotics, applying safety precautions are the key to reduce the spread of multidrug resistant strains, methicillin
resistant Staphylococcus aureus in particular.
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Background
Staphylococcus aureus is one of a versatile pathogen and
the main cause of hospital and community acquired
infections, the disease ranging from mild skin infection
to life-threatening sepsis [1]. Moreover, S. aureus evolves
various drug resistance mechanisms, subsequently re-
sults difficulty in the management of infections. Resist-
ance is, of course, the evolutionary consequence of the
deployment of selective pressure; therefore, it has been
well indicated among pathogenic bacteria including S.
aureus. Following discovery of penicillin 1940s, penicillin-
ase producing S. aureus were demonstrated, leading to de-
velopment of semi-synthetic penicillins such as methicillin,
which was the most effective antibiotics for penicillin re-
sistant strains [2, 3]. Despite the fact that, the antibiotic
was no longer effective due to the emergence of methicillin
resistant S.aureus (MRSA), which has become a grave pub-
lic health concern because of higher mortality and morbid-
ity due to invasive systemic infections [4, 5].
Methicillin resistant largely attributed by due to acquisi-
tion of mecA gene, found in the Staphylococcal cassette
chromosome mec (SCCmec) that codes unique penicillin
binding protein (PBP2a), which has low affinity to methi-
cillin and other beta-lactam antibiotics. Recently, new
resistance gene so called mecC as also identified from
MRSA isolates from clinical specimens. Methicillin resist-
ant Staphylococcus aureus has mostly considered a naso-
comial pathogen since it is increasingly associated with
prior exposure to health care facility. Surprisingly, new
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MRSA variants were also reported from community set-
tings lacking traditional risk factors. Since then, it is
well understood that there are two distinct types of
MRSA were recognized; hospital-acquired and community-
acquired MRSA. Hospital-acquired MRSA strains are re-
sistant not only to beta-lactam agents but also to other
types of antibiotics, and mostly associated with type I, II
and III SCCmec. However, community-acquired MRSA
strains are usually resistant to beta-lactams but susceptible
to other antimicrobials, and linked mostly with the
SCCmec type IV and V [6, 7].
According to the evidences, the burden of MRSA has
been increasing at an alarming pace throughout the world
with showing considerable variation in prevalence accord-
ing of geographical area or region [8, 9]. Understanding
the overall epidemiology of MRSA at country level is so
substantial to underpin effective prevention and control
strategies. Therefore, the aim of this meta-analysis was to
summarize available data and to determine pooled preva-
lence MRSA and its antibiotic resistance in Ethiopia by
conducting a systematic review and meta-analysis.
Methods
Study selection
A literature search was conducted in the PubMed, Lan-
cet and Google Scholar databases and articles potentially
relevant to our study were identified. The search was
performed by six authors (SE, FT, AA, FM, WB and KH)
independently, by using the following terms as keywords
(and combinations thereof) “Staphylococcus aureus”, “S.
aureus”, “antibiotic resistance profile of S. aureus”,” preva-
lence”, “methicillin resistant S. aureus”, “MRSA”, and
“Ethiopia”. Among the citations extracted, abstracts were
reviewed in an attempt to retrieve the clinical studies on
MRSA colonization. Articles that were relevant, by title
and abstract, were accessed in full text to determine those
that provided sufficient information to be included in our
meta-analysis. Finally, the references cited by each eligible
study were scrutinized to identify additional articles.
Inclusion and exclusion criteria
Studies were included in our meta-analysis, if they re-
ported extractable data on the prevalence of MRSA in
Ethiopian hospitals or research centers and only English
language papers were imposed. On the other hand, studies
that did not report on a study of MRSA and failed to com-
ply with Ethiopian setting were excluded from the study.
Outcome of interest
The major outcome of interest was the prevalence of
MRSA among total S. aureus clinical isolates. The preva-
lence was calculated by dividing the numbers of MRSA
isolates of the total number of clinically isolated S. aur-
eus. As secondary outcomes of interest, we have also
calculated the pooled resistance pattern of MRSA iso-
lates to specific antibiotics.
Data extraction
Data from eligible studies were extracted independently
by authors and summarized into a spreadsheet. Discrep-
ancies were resolved by consensus. For each of the in-
cluded studies, the following information was extracted;
name of regions, study area/city, study names, year of
the study, study design, types of specimens, numbers of
patients/study participants, total numbers of S. aureus,
proportion of MRSA and references.
Quality control
The quality of eligible studies was checked independ-
ently by three authors (SE, AA, & WB) using a set of
predetermined criteria such as research design, quality
of paper, and employed methods for MRSA isolation.
Data analysis
A random effects model was used to determine pooled
prevalence and the 95% confidence interval (CI), by
employing the approach of DerSimonian and Laird [10].
Besides, Freeman Tukey arcsine methodology was also
used to address stabilizing variances [11]. The standard
approach of inverse variance method to calculate pooled
prevalences does not work well in meta-analysis of single
arm study because, for studies with small or large preva-
lence, the inverse variance method causes the variance
becomes small and the calculated CI may outside the
range. Therefore, Freeman Tukey arcsine methodology
is recommended to correct both variances instability and
CIs [12]. We assessed the heterogeneity of study results
by the use of I2 test. Significant heterogeneity was con-
sidered for P < 0.10 and I2 > 50% [10, 13]. The small
study bias was measured by Begg’s funnel plot [14]. The
overall prevalence of MRSA was pooled by the forest
plot with 95% CI, and regional prevalence was summa-
rized by using figure. In secondary analysis, we have cal-
culated the resistance pattern of MRSA to specific
antibiotics, and was presented by using table. Statistical
analysis was performed by the use of the Open Meta
Analyst (version 3.13) and Comprehensive Meta Ana-
lysis (version 3.1).
Results
Through electronic database search, we have found a
total of 423 abstracts, among these studies, 321 were dis-
regarded after reviewing their titles, 18 were found to be
duplicates, and 64 were excluded because the abstracts
or full text information did not directly related to the
topic of interest i.e. prevalence of MRSA. Finally, 20 arti-
cles fulfilled our eligibility criteria and were subjected to
meta-analysis [15–34] (Fig. 1).
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As presented in Forest plot (Fig. 2), the pooled preva-
lence of MRSA colonization was 32.5% (95% CI, 24.1 to
40.9%; P < 0.001). There was a high level of heterogen-
eity, random model methods (I2 = 96%, P <0.001). Since,
the included studies have been conducted in different
setups, study periods, and study populations, which
could have an effect on the heterogeneity of the included
studies. Symmetry of funnel plot shows small study bias
yielded insignificant effect.
Selected articles were published from 2007 to 2015
and year of study were ranged from 2004 to 2014.
Besides, all included publications were obtained from 4
regions and including the Federal capital city of Ethiopia,
Addis Ababa, but no data was obtained from other re-
gions (Afar, Benishangul-Gumuz, Gambela and Somali).
Most of the studies indicated that various specimens had
been utilized for screening MRSA, especially multisite
swabbing was performed from different parts of the
body, such as, skin, nasal, eye, ear, urethra, throat, vagina
or genital area (Table 1). The lowest and highest propor-
tions of MRSA were reported respectively, from Addis
Ababa and Bahirdar cities [30, 33]. As shown from Fig. 3
the average prevalence of MRSA was also noted in dif-
ferent regions of Ethiopia, hence Southern Ethiopia re-
gion ranked first (40.4%), followed by Oromia region
(39.1%), and Addis Ababa (31.6%), whereas relatively low
magnitude of MRSA were demonstrated from Tigray
region (20.3%).
Furthermore, of the selected articles, seven studies have
extractable data on the antibiotic resistance profile of
MRSA isolates [16, 18, 20, 21, 23, 26, 33]. The pooled re-
sistance rates of MRSA for each tested antibiotics has
been presented Table 2; and therefore, high resistant rates
were observed to penicillin (99.1, 95% CI: 98–100%),
ampicillin (98.1%, 95% CI: 95.7–100%), erythromycin
Fig. 1 Flow chart shows selected articles for meta-analysis
Fig. 2 Forest plot of the pooled prevalence of MRSA in 20 studies, Ethiopia, 2004–2015
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Table 1 Summary of 20 studies reporting the prevalence of MRSA in different parts of Ethiopia, 2004-2015










Cross-sectional study HIV infected pediatric
patients
Skin swab, nasal swab,
and perineum swab
281 73 (26) Lemma et al. 2015 [17]
Gondar February to May 2012 Cross-sectional study VL patients Blood 11 2 (18.2) Endris et al. 2014 [15]
Gondar July 2011 to June 2012 Cross-sectional study Neonates Blood 17 7 (41.2) Gebrehiwot et al. 2012 [24]
Gondar January to June 2011 Cross-sectional study Food handlers Nasal swab 41 4 (9.8) Dagnew et al. 2012 [25]
Gondar September 2009 to
June 2010
Cross-sectional study In and out patient Urine, eye discharge, genital
swab, body fluid, pus, wound
swab and discharge
279 49 (17.6) Anagaw et al. 2013 [22]
Gondar January to June 2010 Cross-sectional study Patients with
post-operative
surgical site Infections
Pus swab 26 9 (34.6) Amare et al. 2012 [27]




162 89 (54.9) Abera et al. 2008 [29]
Debre Markos March to June 2013 Cross-sectional study School children Nasal swab 123 17 (13.8) Reta et al. 2015 [12]
Debre Markos December 2011 to March 2012 Cross-sectional study Patients with surgical
site infection
Wound swab 73 36 (49.7) Kahsay et al. 2014 [16]
Dessie November 2010 to March 2011 Cross-sectional study Healthcare workers Nasal swab 34 15 (44.1) Shibabaw et al. 2013 [22]
Oromia Jimma June to December 2011 Cross-sectional study In and out patient Wound swab 73 56 (76.7) Godebo et al. 2013 [20]
Jimma December 2010 to
June, 2011
Cross-sectional study Primary school children
and prisoners
Nasal swab 169 39 (23.1) Kejela and Bacha, 2013 [19]
Jimma January 2003 to July 2004 Cross-sectional study Out patients Ear discharges, throat and
wound swabs
72 6 (8.3) Gebre-Sealsssie, 2007 [30]
Harar and
Jimma
- Cross-sectional study — Blood, CSF, pus, sputum
and urine




Addis Ababa March to August 2015 Cross-sectional study Post operative
patients
Wound swab 56 6 (10.7) Getachew et al. 2015 [11]
Addis Ababa September 2013 to
April 2014
Cross-sectional study In and out patient Nasal swab, wound swab, ear
discharge, blood, throat swab,
eye swab, vaginal discharge,
urethral discharge, urine, stool,
sputum, CSF and body fluids
194 34/(17.5) Tebelay et al. 2014 [14]
Addis Ababa March to May 2011 Cross-sectional study In and out patient
(burn patients)













Table 1 Summary of 20 studies reporting the prevalence of MRSA in different parts of Ethiopia, 2004-2015 (Continued)
Addis Ababa April to July 2010 Cross-sectional study In and out patient
(burn patients)
Blood and wound swabs 24 5 (20.8) Sewunet et al. 2013 [23]
Tigray Mekelle November 2010 to
January 2011
Cross-sectional study Health care workers Nasal swab and material
from hand
177 36 (20.3) Gebreyesus et al. 2013 [21]
Southern
Ethiopia
Hawassa August 2013 to
December 2014
Cross-sectional study Health care workers Sample from hand and
mobile phones
166 67 (40.2) Daka, 2014 [13]













(97.2%, 95% CI: 23.2–100%) and amoxicillin (97.1%, 95%
CI: 92.7–100%). In contrast, low level of vancomycin re-
sistance has been calculated, 5.3% (95% CI: 0–10.6%).
Discussion
Antibiotic resistance continues to be a global setback in
the management of common bacterial infections dis-
eases. Particularly, the problem of antibiotic resistance is
highly pronounced in resource limited countries, includ-
ing Ethiopia, where infectious diseases are rampant [3].
A first global report on the antimicrobial resistance
claimed that MRSA is one of the most implicated
multidrug resistant (MDR) strains, which has shown a
high level of resistance against both beta lactam and
non-beta lactam agents [35].
To date, the overall epidemiology and burden of MDR
bacteria have not fully understood, especially in resource
limited countries [3, 35]. To the best of our knowledge,
it is the first a meta-analysis study conducted to deter-
mine pooled prevalence of MRSA in Ethiopia. According
to this meta-analysis, the overall estimation of MRSA
prevalence in Ethiopia was 32.5% (95% CI, 24.1 to 40.9%;
P < 0.001). This is comparable with meta-analysis studies
conducted in similar settings [36–40]. However, this
Fig. 3 Proportion of MRSA in different regions of Ethiopia, 2004–2015
Table 2 Pooled antibiotic resistance rates of MRSA strains; Ethiopia, 2006-2014
Antibiotics Antibiotic resistance rate reported by 7 studies Pooled resistance














Chloramphinicol 4 (5.5) 22 (44.9) - - 0 23 (59) 16 (47.1) 30.8 (30.3–63.8)
Ceftriaxone 15 (20.5) 2 (4.1) 85 (95.5) - 0 - 30.8 (0–84.1)
Ciprofloxacin 17 (23.3) 2 (4.1) 67 (75.3) - 0 - 28 (82.4) 37.3 (5.9–68.7)
Clindamycin 6 (8.2) 1 (2) - 22 (61.1) 0 - 18 (52.9) 23.1 (7.5–38.8)
Cotrimoxazole 4 (5.5) 22 (44.9) - 36 (100) 2 (11.8) 7 (17.9) 34 (100) 46.4 (8.4–84.5)
Erythromycin 17 (23.3) 9 (18.4) 69 (77.5) 35 (97.2) 0 24 (61.5) 34 (100) 97.2 (23.2–100)
Tetracycline 53 (72.6) 10 (20.4) 80 (89.9) 15 (41.7) - 13 (33.3) - 51.9 (22.8–81)
Pencillin G - 49 (100) 89 (100) 36 (100) 17 (100) 39 (100) 34 (100) 99.1 (98–100)
Ampicillin - 46 (93.9) - 36 (100) - 39 (100) - 98.1 (95.7–100)
Amoxacillin - 46 (93.9) - 36 (100) - - 97.1 (92.7–100)
Vancomycin - 0 0 - - 5 (12.8) 10 (29.4) 5.3 (0–10.6)
Gentamycin - - 63 (70.8) 34 (94.4) 0 6 (15.4) 13 (38.2) 44.4 (4.9–83.9)
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finding is relatively higher than from reports indicated in
high income countries [41–43]. It is well known that risk
factors associated with MDR strains are comparatively
higher in developing countries [3, 44].
Reasonably, there are several issues which can be ei-
ther directly or indirectly related to the growing burden
of MDR prevailing bacterial pathogens including MRSA.
Even though, the development of resistance is a normal
evolutionary process for microorganisms, but it is highly
aggravated by continuous deployment of antimicrobial
drugs in treating infections has led to the emergence of
resistance among various strains of bacteria [45, 46]. It
is claimed that more than 50% of drugs prescribed, sold
or dispensed without following standard protocols, and
the situation is more magnified in developing countries
[47]. In low income countries in particular, antibiotic use
is largely relied on clinical judgment without the benefit
of specific diagnostic tools, which inevitably leads to
rapid evolution of drug resistant strains, which is mainly
due to irrational use of antibiotics [48, 49]. Likewise, ac-
cording to Sosa et al. antibiotic use in most of develop-
ing countries is generally unregulated, which is a prime
factor for the occurrence of resistant bacterial strains
[3]. Therefore, it indicated that antibiotics are widely
and inappropriately used in resource limited countries
like Ethiopia, resulting to increased prevalence of drug
resistant strains such as MRSA.
Additionally, regional prevalence of MRSA was also cal-
culated, hence highest prevalence MRSA (40.4%) was noted
in Southern Ethiopia, which was almost two times higher
than a result from Tigary region (20.3%). Though, health
workers were the study population in the studies of both
regions, but as shown in Table 1, different types of sam-
ples were collected from participants (health workers),
and therefore it would have an effect on the isolation
rate of MRSA strains. Besides, the observed variation
might be due to different study location, hospital
setup, and study period.
Moreover, based on the data have been obtained from
seven published articles; MRSA strains showed extremely
high resistance rate to penicillin, ampicillin, erythromycin
and amoxacillin, in contrast least resistance rate was
observed to vancomycin. Similarly, a previous systematic
review [50] has also documented that MRSA strains were
found to be too highly resistant to the above mentioned
antibiotics. It is understood that MRSA strains are able to
express beta-lactam hydrolyzing enzymes so called beta-
lactamases or capable of modifying penicillin binding
proteins [51], hence it is not surprising, MRSA strains are
capable of inactivating the beta-lactam agents such as
penicillin, ampicillin, cephalosporins, and carbapenems.
Even more, MRSA has a propensity to dismantle non-
betam lectam agents; this is largely due to co-existence of
other resistance gene along with mecA or mecC gene
[52]. Most importantly, vancomycin is considerably the
most effective and considered as the last resort treatment
for resistant infections, especially of MRSA, despite the
fact that the emergence of vancomycin resistant organ-
isms has deprived the usefulness of this drug beyond any
doubt [53]. Though low levels of vancomycin resistant in-
dicated in this meta-analysis, but it indicates huge blow,
especially for the future.
In general based on this finding, the burden of MRSA
constitutes a major public health challenge in Ethiopia,
thus health care facilities should adopt or establish
guidelines to minimize cross-contamination by MRSA.
Substantially, maintaining hand hygiene, applying infec-
tion prevention protocols, environmental sanitation, and
wearing possible personal protective equipment are advo-
cated for preventing infection. In addition to that promot-
ing health education, professional educations as well as
public awareness campaigns are evidently effective in the
reduction of the unnecessary use of antibiotics, which in
turn reduce selective pressure of mutant strains.
Conclusion
In this meta-analysis the pooled MRSA prevalence is
considerably high. Aside from that more than 97% of
MRSA strain was found to be highly resistant to beta-
lactam agents (penicillin, ampicillin and amoxacillin)
and non-beta-lactam agents (erythromycin). In contrary,
low level of resistance rate was observed to vancomycin.
Thus, to combat the burden of MRSA in particular, the
following concerns should be considered at the national
level, such as adopting safety protocols and implement-
ing proper antibiotic prescription policies.
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